Skip to content

Response to COVID-19 Vaccines in People with Chronic Conditions

Search Clinical Trials

Trial Objectives


Researchers at National Jewish Health are working to understand the antibody response to COVID-19 vaccines in people with chronic diseases. Researchers are focused on the short-term and long-term antibody response by people with chronic respiratory diseases, as well as other chronic diseases.

Who Can Participate


Individuals 18 and older who have received or will be receiving the COVID-19 vaccine.

Age: 18+ Gender Any

Estimated Time Commitment


Up to 10 visits over the course of about 2 years

Payment & Reimbursement


Payment Provided

Travel Reimbursement Not Available

Trial Contact


For more information, contact:

Madeline Caruso

Juno Pak
303.398.1132

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


Investigator Funded

Principal Investigators

  • Anthony N. Gerber

    Anthony N. Gerber, MD, PhD

  • Barry J. Make

    Barry J. Make, MD

  • Michael E. Wechsler

    Michael E. Wechsler, MD, MMSc

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required